Navigation Links
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MAP Pharmaceuticals, Inc. - MAPP
Date:1/23/2013

NEW YORK, Jan. 23, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of MAP Pharmaceuticals, Inc. ("MAP Pharmaceuticals" or the "Company") (NASDAQ: MAPP) (ISIN: US56509R1086) (CUSIP: 56509R108) concerning the proposed acquisition of MAP Pharmaceuticals by Allergan, Inc. in a transaction valued at approximately $985 million in cash.

The investigation concerns whether the MAP Pharmaceuticals directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value.  Under the terms of the agreement, MAP Pharmaceuticals shareholders will be entitled to receive $25.00 per share in cash for each share of MAP Pharmaceuticals common stock.  However, at least one analyst noted that the offered price undervalues MAP Pharmaceuticals' new migraine treatment drug Levadex.

MAP Pharmaceuticals shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at rswilloughby@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 237.

The firm is also investigating actions on behalf of shareholders for the following companies: Arbitron Inc., Net1 Ueps Technologies, Inc., Hi-Crush Partners LP, Intermec, Inc., SandRidge Energy, Inc., Abiomed, Inc., Universal Technical Institute, and Clearwire Corporation, Ameristar Casinos, Inc. K-Swiss, Inc., Neptune Technologies Bioressources, Inc. Telanetix, Inc.

The Pomerantz Firm, with offices in New York, Chicago and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.


'/>"/>
SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Announces Webcast of Annual Meeting of Shareholders
2. Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product Development Continues with Launch Expected in 2015
3. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
4. Delaware Court of Chancery Dismisses Vermillion Dissident Shareholder Suit with Prejudice
5. SurgLine International, Inc. Shareholder Update
6. Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
7. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
8. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
9. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
10. Medbox Announces Increase in Shareholder Base and Record Revenue Generated in Q3
11. Cardinal Health Announces Preliminary Shareholder Voting Results at 2012 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... 2020 , ... Dr. Mark Surrey has been in practice for over ... clinical professor in the Department of OBGYN at UCLA’s David Geffen School of Medicine. ... Reproductive Society and is a Clinical Director of Fellowship Training for UCLA & Cedars ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bleep LLC, maker of ... sleep apnea patient, is the company’s new spokesperson. , “In my line of work, ... when I found the Bleep DreamPort it was a Bleeping no brainer for me,” ...
(Date:8/26/2020)... ... August 26, 2020 , ... AseptiScope, a privately funded San Diego, California ... Year by MedTech Outlook. , “AseptiScope is pleased to receive this recognition,” ... who wear gloves on their hands, goggles on their eyes, covers on their shoes, ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... ... 2021 will be held Wednesday, April 7, to Saturday, April 10, 2021, at ... Medical Spa Show is a national trade show for non-invasive medical aesthetic practices ...
(Date:9/2/2020)... WASHINGTON, Pa. (PRWEB) , ... September 02, 2020 ... ... development of enterprise software for healthcare payers administering Medicare Advantage and Special Needs ... Duals Online presented by America’s Health Insurance Plans (AHIP). RAM is supporting the ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the ... with Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for ... code (R code) in the next edition of the U.S. International Classification of ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) to ... for cardiac patients who have undergone open heart surgery. , The AGH/CMU team ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, Mississippi-based ... to medical first responders across the United States. Since the start of the ... equipment (PPE) medical centers , hospitals , firefighters , and ...
Breaking Medicine News(10 mins):